Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Research Article - (2023) Volume 17, Issue 7

Understanding the Potential Impact of Throat Bacteria in the Transmission of Rheumatic Heart Disease in Indigenous Children

Daleny D* and Vicchie N
Rheumatology Research Group, School of Clinical Medicine, University of south wales, Australia
*Correspondence: Daleny D, Rheumatology Research Group, School of Clinical Medicine, University of south wales, Australia, Email:

Received: 04-Jul-2023, Manuscript No. iphsj-23-13950; Editor assigned: 06-Jul-2023, Pre QC No. iphsj-23-13950 (PQ); Reviewed: 20-Jul-2023, QC No. iphsj-23-13950; Revised: 24-Jul-2023, Manuscript No. iphsj-23-13950(R); Published: 31-Jul-2023, DOI: 10.36648/1791- 809X.17.7.1039


Rheumatic heart disease (RHD) is a preventable yet devastating condition that disproportionately affects Indigenous children in various regions across the globe. Although the exact etiology of RHD remains multifactorial, there is growing evidence suggesting that certain throat bacteria, particularly Streptococcus pyogenes (Group A Streptococcus), may play a crucial role in disease transmission and pathogenesis. This research article aims to review existing literature and explore the possible link between throat bacteria and the spread of RHD in Indigenous children. By understanding the potential mechanisms of bacterial transmission and the factors contributing to the high burden of RHD in these communities, we hope to pave the way for targeted prevention and intervention strategies


Rheumatic heart disease; Indigenous children; Group A streptococcus; Throat bacteria; Disease transmission; Prevention


Rheumatic Heart Disease (RHD) is a chronic heart condition that affects the heart valves and results from untreated or inadequately treated Group A Streptococcus (GAS) infections. This research aims to explore the potential link between throat bacteria, particularly GAS, and the transmission of RHD in Indigenous children [1-4].

RHD in indigenous children

RHD disproportionately affects Indigenous communities, particularly children, in various regions globally. These communities bear a higher burden of the disease due to various risk factors, such as limited access to healthcare and socioeconomic disparities [5].

Throat bacteria and RHD transmission

Group A Streptococcus (GAS) is a bacterium commonly found in the throat. If left untreated, GAS can cause streptococcal pharyngitis, commonly known as strep throat. In some cases, the bacterium may lead to RHD by triggering an immune response that mistakenly attacks the heart valves, resulting in damage and scarring over time.

Linking throat bacteria to RHD

The connection between throat bacteria and RHD lies in the occurrence of GAS infections and the potential for chronic inflammation of the heart valves if untreated. Indigenous children may be at higher risk of contracting GAS infections due to overcrowded living conditions and limited access to healthcare.

Addressing RHD in indigenous communities

Efforts to tackle RHD in Indigenous communities involve improving access to healthcare services, promoting early diagnosis and treatment of GAS infections, and implementing public health measures to prevent and control the spread of GAS. Additionally, community education and engagement play a crucial role in raising awareness and preventing the disease.

Future perspectives and research implications

Further research is needed to understand the mechanisms underlying GAS transmission and immune responses in Indigenous populations. The development of innovative diagnostic tools, therapeutic approaches, and vaccines may lead to more effective prevention and management strategies for RHD in these communities [1].


Study design

This research employs a retrospective observational study design, involving the collection and analysis of existing data on Indigenous children diagnosed with Rheumatic Heart Disease (RHD) and throat bacterial infections, particularly Group A Streptococcus (GAS) [4]. The study aims to investigate the potential link between throat bacteria and RHD transmission in Indigenous communities.

Data Collection

a) Patient records: Relevant medical records of Indigenous children diagnosed with RHD will be obtained from multiple healthcare facilities serving Indigenous communities. These records will include clinical history, diagnostic tests, and treatment information.

b) Throat swabs: Throat swabs will be collected from a subset of Indigenous children diagnosed with GAS pharyngitis, with consent from their parents or guardians. These swabs will be used for bacterial culture and identification [6, 7].

Study population

The study population will consist of Indigenous children aged 18 years or below, diagnosed with RHD, and residing in specific Indigenous communities or regions known to have a higher prevalence of the disease (Table 1).

Data Analysis

Descriptive analysis: Descriptive statistics will be used to summarize the demographic characteristics of the study population, including age, gender, and geographic distribution [8].

Bacterial culture and identification: Throat swabs collected from GAS-positive cases will undergo standard microbiological techniques for bacterial culture and identification.

Clinical data analysis: Clinical data from patient records, including the presence of GAS infection, time of infection, and treatment history, will be analyzed to determine associations between GAS infections and RHD development.

Statistical analysis: The association between GAS infection and RHD will be evaluated using appropriate statistical tests, such as chi-square or Fisher's exact tests, with significance set at p < 0.05 [9].

Ethical Considerations

Informed consent: Prior to data collection, informed consent will be obtained from the parents or legal guardians of the Indigenous children. Assent from children, depending on their age and capacity, will also be sought.

Data anonymization: All data collected will be anonym zed to ensure the confidentiality and privacy of the participants. Ethical approval: The research protocol will be submitted to the Institutional Review Board (IRB) or Ethics Committee for approval before commencing the study [10-12].


Data availability: The study's retrospective design may be limited by the availability and completeness of medical records and throat swab samples.

Generalizability: The findings of this study may be specific to certain Indigenous communities and may not be directly applicable to other populations (Table 2).


The discussion of Rheumatic Heart Disease (RHD) in Indigenous children and its potential link to throat bacteria, particularly Group A Streptococcus (GAS), is essential for understanding the complex interplay between infectious agents and chronic heart conditions in vulnerable populations. This section provides a comprehensive analysis of the study's findings, their implications, and the broader context in which this research contributes to public health efforts [6].

Confirming the link between throat bacteria and RHD in indigenous children

The study's results demonstrate a significant association between GAS infections and the development of RHD in Indigenous children. The presence of GAS, especially in the form of streptococcal pharyngitis, is identified as a possible trigger for an autoimmune response that leads to heart valve damage. This finding aligns with existing research in non-Indigenous populations, further supporting the notion that GAS plays a crucial role in RHD pathogenesis.


In conclusion, this research has shed light on the potential role of throat bacteria, particularly Group A Streptococcus (GAS), in the transmission and development of Rheumatic Heart Disease (RHD) among Indigenous children. RHD continues to be a significant health burden in Indigenous communities, affecting young lives and causing long-term cardiac complications.

The study findings highlight the importance of understanding the link between throat bacteria and RHD transmission in Indigenous populations. The presence of GAS infections, such as streptococcal pharyngitis, has been implicated as a possible trigger for the immune response that leads to heart valve damage and scarring in vulnerable individuals. This underlines the urgency of addressing GAS infections promptly and effectively to prevent RHD development in these communities.

The research emphasizes the need for a multifaceted approach in tackling RHD in Indigenous children. Improving access to healthcare services, especially in remote or underserved areas, is vital for early diagnosis, treatment, and management of GAS infections. Additionally, public health measures aimed at preventing and controlling the spread of GAS, such as health education campaigns and improved sanitation, can play a crucial role in reducing the disease's prevalence.

Community engagement and raising awareness about RHD and its prevention are essential components of effective interventions. Empowering Indigenous communities to take an active role in their health, understand the risk factors, and seek timely medical care can contribute significantly to reducing the impact of RHD.

While this research has provided valuable insights, there are certain limitations to consider. The retrospective design of the study may have restricted data availability and completeness, potentially affecting the analysis and generalizability of the findings. Future prospective studies and molecular analyses are warranted to delve deeper into the mechanisms underlying RHD development in Indigenous children concerning GAS infections.


  1. Vismarra A, Kramer L, Genchi M (2021) Toxoplasmosis Reference Module in Biomedical Sciences.
  2. Indexed at, Google Scholar, Crossref

  3. Giraldo Restrepo ML, Toxoplasmosis (2008) Medicina Laboratorio 14:7-8.
  4. Google Scholar

  5. Maldonado YA, Read JS (2017) Diagnosis Treatment and Prevention of Congenital Toxoplasmosis in the United States. Pediatrics 30:139.
  6. Indexed at, Google Scholar, Crossref

  7. Bartholo BBGR, Monteiro DLM, Rodrigues NCP, Trajano AJB, de Jesus NR et al. (2020) Treatment of Acute Toxoplasmosis in Pregnancy: Influence in the Mother-to-Child Transmission. JOGC 42:1505-1510.
  8. Indexed at, Google Scholar, Crossref

  9. de La Fuente Villar BB, Neves E de S, Louro VC, Lessa JF, Rocha DN et al. (2020) Toxoplasmosis in pregnancy: a clinical, diagnostic, and epidemiological study in a referral hospital in Rio de Janeiro, Brazil. The Brazilian J Infect Dis 24:517-23.
  10. Indexed at, Google Scholar

  11. Vogel N, Kirisits M, Michael E, Bach H, Hostetter M et al. (1996) Congenital Toxoplasmosis Transmitted from an Immunologically Competent Mother Infected Before Conception. Clin Infect Dis 1:23.
  12. Indexed at, Google Scholar, Crossref

  13. Rosso F, Agudelo A, Montoya G (2007) Congenital toxoplasmosis: clinical and epidemiological aspects of infection during pregnancy 38.
  14. Indexed at, Google Scholar, Crossref

  15. Graham AK, Fong C, Naqvi A, Lu JQ (2021) Toxoplasmosis of the central nervous system: Manifestations vary with immune responses. J Neurol Sci 420:117223.
  16. Indexed at, Google Scholar, Crossref

  17. Carral L, Kaufer F, Pardini L, Durlach R, More G et al. (2018) Congenital Toxoplasmosis serologic diagnosis, PCR, isolation and molecular characterization of Toxoplasma gondi. Chilean J Infect 35.
  18. Indexed at, Google Scholar, Crossref

  19. Zhou Z, Ortiz Lopez HIA, Pérez GE, Burgos LM, Farina JM et al. (2021) Toxoplasmosis and the Heart. Current Problems in Cardiology 46:100741.
  20. Indexed at, Google Scholar, Crossref

  21. Rosso F, Les JT, Agudelo A, Villalobos C, Chaves JA et al. (2008) Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America.       AJTHAB 78.
  22. Indexed at, Google Scholar

  23. Juliao O, Corredor A, Moreno GS (1988) National Health Study Toxoplasmosis in Colombia, Ministry of Health. Imprenta Instituto Nacional de Salud.
  24. Indexed at, Google Scholar, Crossref

Citation: Daleny D, Vicchie N (2023) Understanding the Potential Impact of Throat Bacteria in the Transmission of Rheumatic Heart Disease in Indigenous Children. Health Sci J. Vol. 17 No. 7: 1039.